Collplant Biotechnologies Ltd (CLGN)

Collplant Biotechnologies Ltd (CLGN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $7.4M; returns 1 day +1.4%, 1 week +1.2%, 1 year -83.9%.

CollPlant Biotechnologies Ltd. (CLGN) is a regenerative and aesthetic medicine company focused on developing plant-based recombinant human collagen (rhCollagen) technologies for tissue regeneration, organ manufacturing, and medical aesthetics.

Groups CLGN belongs to

• Recent Reverse Splits
• Israel Companies
• Regenerative Medicine
• Biotechnology
• Israel
• Life Sciences
• Health and Wellness Products
• Medical Devices
• Biopharmaceutical
• Clinical Stage

CLGN financial model: income statement, cash flow and balance sheet